Xenon Pharmaceuticals (XENE) Interest & Investment Income (2013 - 2026)
Xenon Pharmaceuticals (XENE) reported Interest & Investment Income of $6.9 million for Q1 2026, down 14.55% year-over-year from $8.1 million in Q1 2025, and up 29.34% quarter-over-quarter from $5.3 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Interest & Investment Income (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of Interest & Investment Income data on file, last reported at $6.9 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $6.9 million, down 14.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.7 million (down 33.67% YoY), and the FY2025 annual result was $26.8 million, down 36.04% from the prior year.
- Interest & Investment Income advanced to $6.9 million in Q1 2026 per XENE's latest filing, from $5.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $11.4 million in Q1 2024 and troughed at $368000.0 in Q1 2022.
- A 5-year average of $6.6 million and a median of $6.9 million in 2026 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 5278.95% in 2022, then tumbled 43.32% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $4.5 million in 2022, then soared by 94.73% to $8.7 million in 2023, then advanced by 8.41% to $9.4 million in 2024, then plunged by 43.32% to $5.3 million in 2025, then gained by 29.34% to $6.9 million in 2026.
- Business Quant data shows XENE's Interest & Investment Income at $6.9 million in Q1 2026, $5.3 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | 6.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 6.21 Mn |
| Jun 30, 2025 | 7.20 Mn |
| Mar 31, 2025 | 8.08 Mn |
| Dec 31, 2024 | 9.42 Mn |
| Sep 30, 2024 | 10.33 Mn |
| Jun 30, 2024 | 10.84 Mn |
| Mar 31, 2024 | 11.36 Mn |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 6.98 Mn |
| Jun 30, 2023 | 6.52 Mn |
| Mar 31, 2023 | 5.42 Mn |
| Dec 31, 2022 | 4.46 Mn |
| Sep 30, 2022 | 3.07 Mn |
| Jun 30, 2022 | 816,000.00 |
| Mar 31, 2022 | 368,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 72,000.00 |